Moflora formula was developed to nourish and re-balance the entire gastro-intestinal tract. In an eight year period, over 6 million dollars were spent conducting tests on the efficiencies of probiotics.

The bacterial cultures in the Ejuva intestinal cleansing program were isolated in 1940 from the cells of healthy adults. Through processes of selective isolation, strains of bacteria were developed which, in their needs and characteristics, resemble those found in human intestines. As a result of this research, the BT1386 strain of L. Acidophilus was found to be most compatible with conditions in the human gastrointestinal tract. The ability of this strain to cling to the intestinal walls is 15 times greater than that of conventional products. The Ejuva L. Acidophilus and Bifidobacterium, Bifidus, and Infantis strains complement each other and have been documented to attach better to human cells. The strains used in most commercially available L. Acidophilus products were originally isolated from animals and intended for use in the dairy and animal feed industry. Non-human specific preparations do not attach well and can be rejected by our immune system.

In addition to Moflora’s exceptionally stable storage life, its unique formulation allows it to resist stomach acid and bile. High post-digestion survival levels result. On the day of production there are 20 billion micro-organisms per gram of Lactobacillus acidophilus, Lacto-bacillus lactis, Bifidobacterium Bifidum, Bifidobacterium infantis, Lactobacillus plantarum, Lacto-bacillus salifarius, and Lactobacillus casei in a base of vegetable fructo-oligosaccharides. Moflora is lactose free and is certified to be free of E. Coli, Salmonella, Staph. and other pathogens.